Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07140809 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

a Phase 1b/2a Study of JMT202 Injection in Participants With Hypertriglyceridemia

Study acronym: phase Ib/Ⅱa st
StatusRecruiting
PhasePhase 1/2
Started2025-09-09
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 30, 2025 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2025-12-22
Not Yet Recruiting→Recruiting Study Identification, Study Status, Oversight, Eligibility, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2026-05-31→2026-07-31
Completion date2026-08-01→2026-10-01
Study sites0→1
Eligibility criteria+387 characters
[...] st TG test was less than 7 days before administration (D1). TheParticipants useneed ofto meet: Receive stable lipid-lowering drugstreatment for ≥28 days before screening; Accept lipid-lowering medications before screening of less than 28 days, but random stable lipid-lowering therapy, 28 days or more before test TG and D - 1 > 300 mg/dL (the tendency for 3.39 L) screening of unused lipid-lowering within 28 days before, During the screening period, at least one screening should meetbe theconducted followingat requirements:a concentration of 300 mg/dL (3.39 mmol/L) ≤TG<500 mg/dL (5.65 mmol/L). S [...] [...]
2025-08-26
Study Identification, Study Status, Arms and Interventions v1
Study title-83 characters
a Phase Ib1b/Ⅱa2a Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetic Characteristics of JMT202 Injection in Participants With Hypertriglyceridemia
2025-08-22
Original filing
To evaluate the safety and tolerability of multiple subcutaneous injections of JMT202 injection in Chinese participants with hypertriglyceridemia
Trial Details
NCT Number NCT07140809
Lead Sponsor Shanghai JMT-Bio Inc.
Conditions Hypertriglyceridemia
Enrollment 48 participants
Start Date 2025-09-09
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-30